eli lilly blows past estimates, hikes guidance as zepbound, mounjaro sales soar
Published 3 months ago • 2.5K plays • Length 1:54
Download video MP4
Download video MP3
Similar videos
-
1:41
eli lilly stock earnings blows past estimates, hikes guidance as zepbound, mounjaro sales soar
-
2:04
eli lilly results blow past estimates on strong zepbound launch, surging mounjaro revenue
-
2:34
eli lilly stock tumbles 10% after drug giant misses estimates and slashes profit guidance
-
7:14
eli lilly ceo david ricks on q3 results: the underlying growth story is fantastic
-
0:27
eli lilly now selling zepbound vials at 50% discount
-
6:00
eli lilly's zepbound may be best-in-breed for weight loss drugs, says dr. kavita patel
-
7:51
2 months on mounjaro
-
30:33
eli lilly ceo dave ricks on revolutionizing healthcare and medicine
-
14:42
one month on mounjaro results! big weight loss with pcos
-
6:43
eli lilly ceo on weight loss drugs outlook: our top priority is making more product
-
3:53
eli lilly's alzheimer drug is 'a nice additional therapy', says mizuho's jared holz
-
0:59
eli lilly ceo on why food companies haven't seen a big impact on sales
-
0:55
eli lilly ceo on compounded versions of weight loss drugs
-
3:36
lilly lowers forecast on weight-loss disappointment
-
5:27
eli lilly's drop after earnings is a buying opportunity, says mizuho's jared holz
-
3:45
three-stock lunch: eli lilly, transdigm, & nvidia
-
3:51
eli lilly stock tumbles on q3 miss, zepbound sales fall short
-
3:49
eli lilly beats on quarterly profit hikes full-year guidance on strong
-
1:38
chart of the day: eli lilly
-
3:15
mounjaro remains the single largest driver for eli lilly stock in the near term: mizuho's jared holz
-
3:17
bofa's geoff meacham on eli lilly on q4 results: the story has changed to diabetes and obesity
-
1:46
eli lilly releases new form of weight loss drug zepbound for half the price to boost access, supply
Clip.africa.com - Privacy-policy